These DEGs were enriched in cancer-related pathways including cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, primary immunodeficiency, and intestinal immune network for IgA production (Figure 2(f)). The gene discussed is CD79A; the disease is cancer.